Skip to main content

Table 2

From: Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy

Variables

ATP-III Adj. OR (95% CI)

P-value

EGIR Adj. OR (95% CI)

P-value

IDF Adj. OR (95% CI)

P-value

Lipoatrophy

1.14 (0.66; 1.96)

0.63

1.20 (0.71; 2.03)

0.49

1.21 (0.79; 1.84)

0.37

Central adiposity

1.87 (0.99; 3.53)

0.054

2.88 (1.64; 4.27)

0.001

2.14 (1.21; 3.79)

0.009

Mixed form

2.06 (1.26; 3.37)

0.004

2.65 (1.64; 4.27)

<0.0001

2.12 (1.43; 3.14)

<0.0001

% fat legs (10%)

1.04 (0.82; 1.32)

0.73

0.73 (0.57; 0.93)

0.013

0.91 (0.74; 1.13)

0.41

VAT/TAT

12.35 (4.84; 31.48)

<0.0001

2.80 (1.16; 6.78)

0.022

2.37 (1.08; 5.21)

0.031

BMI

      

<19

0.33 (0.13; 0.86)

0.024

0.30 (0.12; 0.78)

0.014

0.51 (0.28; 0.92)

0.027

between 19 and 25

Ref.

-

Ref.

-

Ref.

-

between 25 and 30

2.12 (1.51; 2.99)

<0.0001

2.36 (1.70; 3.28)

<0.0001

2.42 (1.76; 3.32)

<0.0001

>30

5.56 (3.04; 10.16)

<0.0001

12.38 (6.28; 24.43)

<0.0001

5.99 (3.02; 11.90)

<0.0001